↓ Skip to main content

Thymoquinone attenuates cisplatin-induced hepatotoxicity via nuclear factor kappa- β

Overview of attention for article published in BMC Complementary Medicine and Therapies, August 2014
Altmetric Badge

Citations

dimensions_citation
92 Dimensions

Readers on

mendeley
69 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Thymoquinone attenuates cisplatin-induced hepatotoxicity via nuclear factor kappa- β
Published in
BMC Complementary Medicine and Therapies, August 2014
DOI 10.1186/1472-6882-14-282
Pubmed ID
Authors

Abdulrahman L Al-Malki, Ahmed Amir Radwan Sayed

Abstract

Cisplatin (CP) is known as a potent anti-cancer drug. The most therapeutic adverse effect of CP is induced hepatotoxicity. In the present study, the protective effect of thymoquinone (TQ) on CP-induced hepatotoxicity was studied.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 69 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Indonesia 1 1%
United States 1 1%
Sri Lanka 1 1%
Unknown 66 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 12 17%
Researcher 8 12%
Student > Master 6 9%
Student > Bachelor 6 9%
Student > Doctoral Student 4 6%
Other 14 20%
Unknown 19 28%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 12 17%
Medicine and Dentistry 10 14%
Agricultural and Biological Sciences 10 14%
Biochemistry, Genetics and Molecular Biology 6 9%
Veterinary Science and Veterinary Medicine 2 3%
Other 5 7%
Unknown 24 35%